The initial method used to administer fat-dissolving injections, as previously discussed, was mesotherapy, and this method is still used to this day. This process consists of multiple subdermal injections of small amounts of substance (Initially these injections were also intradermally but now will always be subdermal.)

​

More recently the preferred method of administering the SDC, particularly desobody/desoface, has been through a technique called intralipotherapy.  Whereas mesotherapy required multiple injection sites to be used this new technique instead only requires two or three such sites. Intralipotherapy also allows the adipocytlytic agent to be released directly into the fatty tissue homogenously, and also at different levels. This, in turn, reduces the formation of nodules or irregularities on the skin.

​

First, the patient will be photographed in a standing position with marks drawn and measured so that the treatment is properly documented from start to finish. Next, a needle between 70 and 100mm long is inserted beneath the skin and using a retrograde fan technique this is then used to treat the entirety of the tissue’s surface. The procedure is almost entirely pain-free, although a small dose of 2% lidocaine is recommended to reduce any slight discomfort that may be felt.

​

Several sessions are required to complete the procedure, typically three, with three or four weeks between each session. This gap between each treatment is crucial in allowing the body’s normal inflammatory response to trigger and subside before more substance is applied.